Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €80.00 ($88.89) price target from equities research analysts at Bankhaus Lampe in a research note issued on Monday. The brokerage presently has a a “neutral” rating on the stock.

Other equities research analysts also recently issued reports about the company. Morgan Stanley set a €97.00 ($107.78) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Monday, August 8th. Goldman Sachs Group Inc. set a €94.00 ($104.44) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Tuesday, June 28th. Berenberg Bank set a €94.00 ($104.44) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Friday, July 22nd. BNP Paribas set a €80.00 ($88.89) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research report on Wednesday, August 3rd. Finally, Nord/LB set a €93.00 ($103.33) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Monday, August 8th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and fourteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of €88.97 ($98.86).

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Fresenius Medical Care AG & Co. (ETR:FME) traded up 0.85% during trading on Monday, hitting €75.22. The stock had a trading volume of 1,197 shares. The company has a market cap of €23.00 billion and a P/E ratio of 20.85. The company has a 50 day moving average of €78.84 and a 200-day moving average of €78.08. Fresenius Medical Care AG & Co. has a 12-month low of €67.50 and a 12-month high of €85.52.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Receive News & Stock Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related stocks with our FREE daily email newsletter.